Birmingham Atrial Fibrillation Treatment of the Aged "BAFTA"
Completed
Phase N/A ResultsSummary of Purpose
To determine whether patients aged 75 years and older with non-rheumatic atrial fibrillation should be treated with aspirin or warfarin.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 13 August 2007.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
Primary care based randomized, controlled trial.
Contacts
Not available
Recruitment
- Gender: Both
- Minimum Age: 75
- Study Size: 973
- Study Size Planned: 930
- Number of Centers: 330
Principal Investigator
-
Jonathan WF Mant
Department of Primary Care & General Practice, University of Birmingham, UK
Locations
- U.K.